US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

171.50

+1.610.95%

Volume:576.73K

Turnover:99.56M

Market Cap:544.42M

PE:- -

High:177.91

Open:170.28

Low:168.40

Close:169.89

52wk High:198.18

52wk Low:32.55

Shares:3.17M

Float Shares:3.17M

Volume Ratio:0.68

T/O Rate:18.17%

Dividend:1.34

Dividend Rate:0.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Executive Program Spotlight: Global Commercial Health Insurance Innovation Bootcamp

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Jazz Pharmaceuticals (JAZZ) and Talkspace (TALK)

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)

Cross Country Healthcare’s Deal Risks: Terminated Aya Merger Highlights Acquisition Pitfalls and Financial Exposure

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN) and Novo Nordisk (NVO)

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and HCA Healthcare (HCA)

ASX Midday Sector Update: Health Care Stocks Rise, Energy Struggles

MT Newswires Live

American Healthcare REIT Projects Another Year of Growth

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and West Pharmaceutical Services (WST)

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC)

Health Care Up as Novo Nordisk, Hims & Hers Settle Dispute -- Health Care Roundup

Assessing Graham Holdings (GHC) Valuation After Expansion In Healthcare And Education

Simply Wall St.

UnitedHealth to Present at Barclays Global Healthcare Conference

CNL Healthcare Properties Receives Unqualified Audit Opinion from PwC

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Dyne Therapeutics (DYN)

Analysts Conflicted on These Healthcare Names: Hims & Hers Health (HIMS), US Physical Therapy (USPH) and Evaxion Biotech (EVAX)

Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results

Building Momentum With Zusduri: Strong Early Commercial Traction, Expanding Physician Adoption, and Pipeline-Funded Upside Support a Buy Rating

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Mirum Pharmaceuticals (MIRM) and Talkspace (TALK)

FDA's Single Pivotal Trial Policy Seen Driving Drug Pipelines -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":171.5,"timestamp":1773172800000,"preClose":169.89,"halted":0,"volume":576725,"delay":0,"changeRate":0.009476720230737617,"floatShares":3174486,"shares":3174486,"eps":0,"marketStatus":"Pre-Mkt","change":1.61,"latestTime":"03-11 07:26:43 EDT","open":170.28,"high":177.91,"low":168.4,"amount":99555099.984,"amplitude":0.055977,"askPrice":171.5,"askSize":10,"bidPrice":168.72,"bidSize":64,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773235800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":171.5,"sharesOutstanding":3074486,"nav":169.927,"aum":539431184.54,"dividendRate":0.0078,"bidAskSpread":0.001771,"postHourTrading":{"tag":"盘后","latestPrice":171.5,"preClose":171.5,"latestTime":"19:56 EDT","volume":5026,"amount":860673.7631,"timestamp":1773186982574,"change":0,"changeRate":0,"amplitude":0.00758},"volumeRatio":0.6764409140010272,"impliedVol":0.9938,"impliedVolPercentile":0.792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3174486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6764409140010272,"shares":3174486,"dividePrice":1.3377,"high":177.91,"amplitude":0.055977,"preClose":169.89,"low":168.4,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":171.5,"committee":0.72973,"eps":0,"divideRate":0.0078,"volume":576725,"delay":0,"ttmEps":0,"open":170.28,"prevYearClose":159.39,"prevWeekClose":158.47,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":156.86,"twentyDayClose":169.18,"sixtyDayClose":160.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167853425","title":"Executive Program Spotlight: Global Commercial Health Insurance Innovation Bootcamp","url":"https://stock-news.laohu8.com/highlight/detail?id=1167853425","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167853425?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:22","pubTimestamp":1773134556,"startTime":"0","endTime":"0","summary":"The Chinese healthcare industry is undergoing a significant transformation. With the deepening of medical insurance payment reforms, the accelerated development of commercial health insurance, and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","BK4581","BK4588","XBI","LABU"],"gpt_icon":0},{"id":"2618337199","title":"Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Jazz Pharmaceuticals (JAZZ) and Talkspace (TALK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618337199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618337199?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:20","pubTimestamp":1773134424,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zevra Therapeutics (ZVRA – Research Report), Jazz Pharmaceuticals...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zevra-therapeutics-zvra-jazz-pharmaceuticals-jazz-and-talkspace-talk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zevra-therapeutics-zvra-jazz-pharmaceuticals-jazz-and-talkspace-talk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","TALK","BK4585","IE00BN0W2T93.GBP","LU0823416689.USD","BK4588","IE00BN0W2V16.EUR","BK4532","IE00BN0W2W23.USD","JAZZ","BK4581","LU0029874061.USD","LU0889565916.HKD","XLV","LU0320765992.SGD","BK4137","BK4533","HCSG","LU0109394709.USD","LU0154245673.USD","ZVRA","BK4007","LU0154245756.USD","BK4196","XBI","LABU"],"gpt_icon":0},{"id":"2618803359","title":"Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618803359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618803359?lang=en_us&edition=fundamental","pubTime":"2026-03-10 16:10","pubTimestamp":1773130226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rapport Therapeutics, Inc. (RAPP – Research Report),...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-rapport-therapeutics-inc-rapp-jazz-pharmaceuticals-jazz-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-rapport-therapeutics-inc-rapp-jazz-pharmaceuticals-jazz-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","RAPP","XBI","IE00BN0W2T93.GBP","BK4588","JAZZ","LU0889565916.HKD","BLSX","BK4533","BK4581","LU0128526141.USD","BK4585","IE00BN0W2V16.EUR","LU0109394709.USD","LU0823416689.USD","LABU","BK4137","LU0154245673.USD","BLSG","IE00BN0W2W23.USD","BK4112","LU0154245756.USD","LU0029874061.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2618986521","title":"Cross Country Healthcare’s Deal Risks: Terminated Aya Merger Highlights Acquisition Pitfalls and Financial Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2618986521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618986521?lang=en_us&edition=fundamental","pubTime":"2026-03-10 14:00","pubTimestamp":1773122436,"startTime":"0","endTime":"0","summary":"Cross Country Healthcare (CCRN) has disclosed a new risk, in the Corporate Activity and Growth category. Cross Country Healthcare continually evalu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcares-deal-risks-terminated-aya-merger-highlights-acquisition-pitfalls-and-financial-exposure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcares-deal-risks-terminated-aya-merger-highlights-acquisition-pitfalls-and-financial-exposure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","CCRN","BK4196","XLV","LABU","XBI","BK4585","BK4588"],"gpt_icon":0},{"id":"2618988022","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN) and Novo Nordisk (NVO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618988022","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618988022?lang=en_us&edition=fundamental","pubTime":"2026-03-10 12:30","pubTimestamp":1773117012,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report) and Novo No...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neurosense-therapeutics-ltd-nrsn-and-novo-nordisk-nvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neurosense-therapeutics-ltd-nrsn-and-novo-nordisk-nvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","BK4137","BK4599","LU1093756325.SGD","BK4532","NVOH","LU0128526141.USD","IE00BKVL7J92.USD","LABU","BK4585","NVO","BK4007","BK4581","XBI","LU0029874061.USD","NRSN","LU0154236417.USD","LU1093756168.USD","BK4139","IE00BZ1G4Q59.USD","BK4588"],"gpt_icon":0},{"id":"2618867607","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and HCA Healthcare (HCA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618867607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618867607?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:50","pubTimestamp":1773111011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","XBI","XLV","IE00B775SV38.USD","LU1778281490.HKD","LU1035775433.USD","BK4533","LU0109394709.USD","LU1674673428.USD","IE00BJT1NW94.SGD","HCA","SG9999014021.USD","LU1150488135.SGD","LU0757428866.USD","LU0882574055.USD","LU0432979614.USD","IE0002270589.USD","BK4585","LU1267930573.SGD","IE00B19Z3B42.SGD","LU1119994496.HKD","LU0130102774.USD","LU1069344957.HKD","BK4023","LU0310799852.SGD","SG9999013999.USD","LU2237438978.USD","IE00B2B36J28.USD","LU1559883803.SGD","LU2244417387.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LABU","BK4532","LU0203345920.USD","LU0029864427.USD","LU0417517546.SGD","LU1150488218.USD","BK4504","SG9999014013.SGD","BK4588","LU1430594728.SGD","LU0889565916.HKD","LU0310800379.SGD","LU0068578508.USD","IE00B894F039.SGD","LU0433182093.SGD","VRTX","LU0058720904.USD"],"gpt_icon":0},{"id":"2618960455","title":"ASX Midday Sector Update: Health Care Stocks Rise, Energy Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2618960455","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618960455?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:08","pubTimestamp":1773108507,"startTime":"0","endTime":"0","summary":"Health care stocks advanced 2% at midday Tuesday.CSL  shares rose more than 2% in recent trade after the biotechnology company disclosed the $1.5 billion expansion of its Illinois plasma therapy manufacturing facility on Monday.Meanwhile, the energy sector struggled, shedding 4% amid geopolitical tensions in the Middle East.Woodside Energy Group  shares fell past 5% in recent trade, while Santos  shares fell 4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7142","WDS.AU","BK4588","BK7507","BK4581","BK7067","XBI","BK7508","BK7501","XLV","CSL.AU","LABU","BK4585","BK7511","STO.AU"],"gpt_icon":0},{"id":"2618407605","title":"American Healthcare REIT Projects Another Year of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2618407605","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618407605?lang=en_us&edition=fundamental","pubTime":"2026-03-10 08:20","pubTimestamp":1773102035,"startTime":"0","endTime":"0","summary":"American Healthcare REIT, Inc. (($AHR)) has held its Q4 earnings call. Read on for the main highlights of the call. American Healthcare REIT’s late...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-projects-another-year-of-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-projects-another-year-of-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4225","REIT","BK4581","XBI","BK4585","AHR","BK4588"],"gpt_icon":0},{"id":"2618608425","title":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and West Pharmaceutical Services (WST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618608425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618608425?lang=en_us&edition=fundamental","pubTime":"2026-03-10 07:00","pubTimestamp":1773097240,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Voyager Therapeutics (VYGR – Research Report) and We...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-and-west-pharmaceutical-services-wst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-and-west-pharmaceutical-services-wst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","BK4137","BK4139","IE00B64QTZ34.USD","XBI","IE00BYQQ9H92.USD","LU0345774391.USD","BK4121","HCSG","VYGR","LU0029874061.USD","LU0128526141.USD","LU0106261612.USD","XLV","BK4585","LU0345774631.USD","IE00BFXG0V08.USD","BK4504","BK4581","LABU","LU0012050646.USD","WST","BK4588"],"gpt_icon":0},{"id":"2618608571","title":"Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618608571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618608571?lang=en_us&edition=fundamental","pubTime":"2026-03-10 06:30","pubTimestamp":1773095410,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MacroGenics (MGNX – Research Report) and Cartesian...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-macrogenics-mgnx-and-cartesian-therapeutics-rnac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-macrogenics-mgnx-and-cartesian-therapeutics-rnac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4139","XLV","LU0029874061.USD","HCSG","BK4137","BK4581","MGNX","XBI","BK4585","LU0128526141.USD","RNAC"],"gpt_icon":0},{"id":"2618708726","title":"Health Care Up as Novo Nordisk, Hims & Hers Settle Dispute -- Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2618708726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618708726?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:43","pubTimestamp":1773092580,"startTime":"0","endTime":"0","summary":"Health-care companies rose as a distribution spat was resolved.Wegovy maker Novo Nordisk said it was teaming up with Hims & Hers Health to sell its weight-loss drugs through the telehealth company's platform, bringing an end to a legal dispute between the two companies. Shares of Hims & Hers jumped, logging their largest percentage gains on record.Vaccine makers rose after the Food and Drug Administration's controversial vaccines chief, Dr. Vinay Prasad, stepped down.British drug giant GSK said it would sell rights to linerixibat, an experimental treatment for itching caused by a liver disease, to Italian pharmaceutical company Alfasigma as part of a licensing agreement valued at up to $690 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","BK4599","LU1093756325.SGD","XBI","LU1093756168.USD","NVOX","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LABU","BK4585","LU0154236417.USD","NVOH","BK4581","HIMS","BK4007","BK4588","BK4532"],"gpt_icon":1},{"id":"2618230670","title":"Assessing Graham Holdings (GHC) Valuation After Expansion In Healthcare And Education","url":"https://stock-news.laohu8.com/highlight/detail?id=2618230670","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618230670?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:23","pubTimestamp":1773091396,"startTime":"0","endTime":"0","summary":"Event driven snapshot on Graham Holdings (GHC)\nRecent news around Graham Holdings (GHC) centers on expansion in healthcare and education, including the acquisition of Covenant Home Health in Eastern Pennsylvania and new program partnerships through its Kaplan subsidiary.\nSee our latest analysis for Graham Holdings.\nRecent earnings and impairment charges, along with the confirmed dividend, have come alongside a 1-year total shareholder return of 18.24%. A 30-day share price return of a 7.73%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3112400-choice2-main-header/1585186895258","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112400-choice2-main-header/1585186895258"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/nyse-ghc/graham-holdings/news/assessing-graham-holdings-ghc-valuation-after-expansion-in-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nyse-ghc/graham-holdings/news/assessing-graham-holdings-ghc-valuation-after-expansion-in-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","XBI","LABU","DCF","BK4588","BK4137","LU0128526141.USD","BK4204","LU0029874061.USD","HCSG","XLV","BK4585","GHC"],"gpt_icon":0},{"id":"2618867717","title":"UnitedHealth to Present at Barclays Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2618867717","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618867717?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:10","pubTimestamp":1773090629,"startTime":"0","endTime":"0","summary":"An update from UnitedHealth ( ($UNH) ) is now available. UnitedHealth Group said senior leaders will participate in an interview-style session at t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/unitedhealth-to-present-at-barclays-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/unitedhealth-to-present-at-barclays-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0048584097.USD","LU0661504455.SGD","IE00B19Z9505.USD","LU0211326839.USD","LU1153585028.USD","LU0122379950.USD","IE00B1XK9C88.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0683600562.USD","LU0820561818.USD","LU1066053197.SGD","LU0949170772.SGD","LU0345770308.USD","LU1674673691.USD","LU2468319806.SGD","UNH","LU0011850046.USD","LU0128525689.USD","IE00B894F039.SGD","LU0795875086.SGD","LU0820561909.HKD","LU1854104046.USD","LU1934455863.HKD","UNHW","LU0128525929.USD","BK4154","LU0965509283.SGD","SGXZ81514606.USD","BK4532","IE00B4JS1V06.HKD","LABU","LU0128526141.USD","LU0266013472.USD","LU0708995401.HKD","IE00B4R5TH58.HKD","LU0353189680.USD","LU0738911758.USD","IE00BFTCPJ56.SGD","LU1037948541.HKD","LU0316494557.USD","LU1791710582.SGD","IE00B1BXHZ80.USD","LU1064131342.USD","LU2271345857.HKD","LU2361044865.SGD","LU2362541513.USD","LU1267930227.SGD","LU0310800965.SGD","LU2552382215.SGD","LU1261432733.SGD","LU1035773651.USD","LU1718418525.SGD","BK4581","LU0456855351.SGD","LU1323610961.USD","IE000M9KFDE8.USD","LU0149725797.USD","LU0965509101.SGD","IE0002141913.USD","LU2357305700.SGD","LU0053666078.USD","SGXZ31699556.SGD","LU2112291526.USD","LU0795875169.SGD","LU2324357040.USD","LU2552382058.USD","LU0342679015.USD","LU0496365809.HKD","LU1267930573.SGD","LU1934455194.USD","LU1061106388.HKD","LU2361044949.HKD","LU1057294990.SGD","LU0345770993.USD","LU1003077747.HKD","LU0672654240.SGD","LU1791710400.SGD","LU0557290698.USD","LU1267930730.SGD","LU0976567544.SGD","LU0310799852.SGD","LU1267930490.SGD","LU2347655156.SGD","LU0689472784.USD","LU0882574055.USD","SG9999018865.SGD","LU0354030511.USD","LU1732799900.SGD","LU0052756011.USD","LU2491049909.HKD","SGXZ99366536.SGD","LU0823416689.USD","SG9999014906.USD","LU1854103824.USD","LU1989771016.USD","LU0417517546.SGD","BK4533","LU2125154935.USD","LU1814569148.SGD","LU0820562030.AUD","SG9999017495.SGD","IE0004445015.USD","LU0203345920.USD","LU2461242641.AUD","IE0009355771.USD","IE00BZ9MQY76.HKD","LU2361045086.USD","LU2552382132.HKD","LU1119994496.HKD","LU2362541273.HKD","LU0545039389.USD","LU1066051225.USD","LU0094547139.USD","IE00BSNM7G36.USD","BK4566","LU0432979614.USD","LU1074936037.SGD","LU1778281490.HKD","LU0310800379.SGD","LU2023251221.USD","LU1914381329.SGD","IE00B19Z9Z06.USD","LU1674673428.USD","SG9999001176.USD","IE00B7KXQ091.USD","IE00B19Z3581.USD","LU0029874061.USD","LU0097036916.USD","LU2211815571.USD","LU1551013342.USD","LU2089284900.SGD","LU0107464264.USD","LU0256863811.USD","LU2491050154.USD","LU2236285917.USD","IE00B19Z9P08.USD","SG9999002232.USD","BK4137","LU0211328371.USD","BK4534","SG9999013999.USD","LU0203347892.USD","LU0353189763.USD","LU0553294199.USD","LU2089984988.USD","IE0004445239.USD","LU2111349929.HKD","LU0114720955.EUR","BK4585","IE00BN29S564.USD","IE00BFSS8Q28.SGD","LU0320765059.SGD","SG9999002224.SGD","LU0234572021.USD","IE00BJJMRX11.SGD","LU1506573853.SGD","LU0708994859.HKD","LU2244417387.USD","SG9999018857.SGD","SGXZ57979304.SGD","LU1496350502.SGD","LU0251132253.USD","IE00BJJMRZ35.SGD","LU1670627923.USD","LU0912757837.SGD","LU0109391861.USD","IE00B19Z8W00.USD","LU1732800096.USD","LU0528227936.USD","LU0289739699.SGD","LU0965509010.AUD","IE00BFXG1179.USD","LU0058720904.USD","UNHG","LU0079474960.USD","LU2360032135.SGD","LU1983299246.USD","LU1551013425.SGD","LU0238689110.USD","XBI","LU2491050071.SGD","LU0943347566.SGD","LU1548497426.USD","LU0354030438.USD","IE00BJJMRY28.SGD","LU0187121727.USD","LU1720051108.HKD","IE0002270589.USD","LU2089283258.USD","LU0198837287.USD","BK4588","IE00B2B36J28.USD","LU2264538146.SGD","LU0158827948.USD","SG9999014898.SGD","LU1291159041.SGD","IE00B775H168.HKD","LU1069347547.HKD","LU0158827781.USD","LU1084165304.USD","LU2125154778.USD","LU2362540622.SGD","IE0005OL40V9.USD","LU1670628061.USD","IE00BFSS7M15.SGD","LU2087625088.SGD","SG9999014914.USD","IE00BKPKM429.USD","LU1988902786.USD","LU1023059063.AUD","IE00BKVL7J92.USD","IE00BWXC8680.SGD","LU0077335932.USD","LU1934455277.USD","LU1037948897.HKD","SG9999014880.SGD","LU0211327993.USD","LU2242649171.HKD","SGXZ51526630.SGD","LU1066051811.HKD","LU2133065610.SGD","LU0787776722.HKD","LU2279689827.SGD","IE00B19Z8X17.USD","IE00B7SZLL34.SGD","IE00BJT1NW94.SGD","LU0029864427.USD","LU0211326755.USD","LU0861579265.USD","LU1066051498.USD","LU1720051017.SGD","LU2028103732.USD"],"gpt_icon":0},{"id":"2618677872","title":"CNL Healthcare Properties Receives Unqualified Audit Opinion from PwC","url":"https://stock-news.laohu8.com/highlight/detail?id=2618677872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618677872?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:54","pubTimestamp":1773089695,"startTime":"0","endTime":"0","summary":"CNL Healthcare Properties ( ($CHTH) ) has issued an announcement. On March 9, 2026, PricewaterhouseCoopers LLP completed audits of CNL Healthcare P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cnl-healthcare-properties-receives-unqualified-audit-opinion-from-pwc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cnl-healthcare-properties-receives-unqualified-audit-opinion-from-pwc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNL","BK4588","LU0029874061.USD","HCSG","LABU","BK4137","XBI","LU0128526141.USD","BK4168","XLV","BK4581","BK4585"],"gpt_icon":0},{"id":"2618677847","title":"Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Dyne Therapeutics (DYN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618677847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618677847?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:50","pubTimestamp":1773089410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jade Biosciences (JBIO – Research Report) and Dyne T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jade-biosciences-jbio-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jade-biosciences-jbio-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","XLV","DYN","LU0128526141.USD","LU0029874061.USD","BK4581","XBI","BK4585","BK4539","HCSG","BK4139","JBIO","BK4505","BK4588"],"gpt_icon":0},{"id":"2618672151","title":"Analysts Conflicted on These Healthcare Names: Hims & Hers Health (HIMS), US Physical Therapy (USPH) and Evaxion Biotech (EVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618672151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618672151?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:30","pubTimestamp":1773088216,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), US Physical Therapy ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-hims-hers-health-hims-us-physical-therapy-usph-and-evaxion-biotech-evax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-hims-hers-health-hims-us-physical-therapy-usph-and-evaxion-biotech-evax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USPH","BK4581","XBI","BK4585","HIMS","BK4185","EVAX","LU0012050646.USD","BK4137","BK4196","HIMZ","HMYY","LU0128526141.USD","HIYY","BK4588","LABU","LU0106261612.USD","HIMY","LU0029874061.USD","BK4139"],"gpt_icon":0},{"id":"2618677538","title":"Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2618677538","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618677538?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:30","pubTimestamp":1773088200,"startTime":"0","endTime":"0","summary":"– The FDA assigned a PDUFA target action date of December 22, 2026 – – The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3252329/0/en/Mineralys-Therapeutics-Announces-FDA-Acceptance-of-NDA-for-Lorundrostat-for-Treatment-of-Adults-with-Hypertension-and-Topline-Explore-OSA-Trial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BMI","BK4007","LU1829250122.USD","BK4157","BK4539","LENZ","BK4097","BP","BK4585","ARB","BPH","LU0072461881.USD","LABU","LU0162691827.USD","BK4167","BK4139","LU1162221912.USD","LU0320765646.SGD","AHI","BK4201"],"gpt_icon":0},{"id":"2618967917","title":"Building Momentum With Zusduri: Strong Early Commercial Traction, Expanding Physician Adoption, and Pipeline-Funded Upside Support a Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618967917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618967917?lang=en_us&edition=fundamental","pubTime":"2026-03-10 02:55","pubTimestamp":1773082525,"startTime":"0","endTime":"0","summary":"Urogen Pharma, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tara Bancroft from TD Cowen maintained a Buy ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/building-momentum-with-zusduri-strong-early-commercial-traction-expanding-physician-adoption-and-pipeline-funded-upside-support-a-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/building-momentum-with-zusduri-strong-early-commercial-traction-expanding-physician-adoption-and-pipeline-funded-upside-support-a-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","LABU","BK4588","XLV","BK4585"],"gpt_icon":0},{"id":"2618676574","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Mirum Pharmaceuticals (MIRM) and Talkspace (TALK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618676574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618676574?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:50","pubTimestamp":1773078610,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Mirum Pharmaceuticals (MIRM – Research Report) and Talkspace (TAL...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-mirum-pharmaceuticals-mirm-and-talkspace-talk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-mirum-pharmaceuticals-mirm-and-talkspace-talk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","BK4137","BK4510","TAL","BK4503","BK4548","BK4531","BK4506","BK4204","HCSG","BK4196","BK4588","LU1880383440.USD","LU0029874061.USD","XLV","TALK","BK4581","BK4139","BK4526","BK4585","LU1880383366.USD","MIRM","LU0128526141.USD","BK4535"],"gpt_icon":0},{"id":"2618675146","title":"FDA's Single Pivotal Trial Policy Seen Driving Drug Pipelines -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2618675146","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618675146?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:36","pubTimestamp":1773077760,"startTime":"0","endTime":"0","summary":"1336 ET - The FDA's new single-trial approval policy could expand pharmaceutical development pipelines, J.P. Morgan analysts say in a research note. In February, the FDA Commissioner unveiled a new default position that just one \"adequate and well-controlled\" study combined with confirmatory evidence will underpin marketing authorization of novel products. While the practice of conducting one, rather than two, pivotal trials is not a new phenomenon, the analysts say the formal implementation of the policy could drive pharmaceutical companies to reinvest savings from fewer Phase 3 trials into discovery and preclinical programs. Long term, this shift could gradually boost the total number of drugs reaching commercialization, the analysts say.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":23,"pageCount":4,"totalSize":453,"code":"91000000","status":"200"}]}}